Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
98.95
+1.00 (1.02%)
At close: Apr 9, 2026, 4:00 PM EDT
99.00
+0.05 (0.05%)
After-hours: Apr 9, 2026, 7:18 PM EDT
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts that cover Mirum Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $115.33, which forecasts a 16.55% increase in the stock price over the next year. The lowest target is $77 and the highest is $132.
Price Target: $115.33 (+16.55%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 | 4 | 4 |
| Buy | 6 | 6 | 6 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $117 → $125 | Strong Buy | Maintains | $117 → $125 | +26.33% | Mar 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $130 | Strong Buy | Reiterates | $130 | +31.38% | Mar 23, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $101 → $126 | Buy | Maintains | $101 → $126 | +27.34% | Mar 4, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $120 → $118 | Buy | Maintains | $120 → $118 | +19.25% | Feb 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $115 → $117 | Strong Buy | Maintains | $115 → $117 | +18.24% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
658.00M
from 521.31M
Increased by 26.22%
Revenue Next Year
803.00M
from 658.00M
Increased by 22.04%
EPS This Year
-1.90
from -0.47
EPS Next Year
0.01
from -1.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 690.5M | 883.9M | |||
| Avg | 658.0M | 803.0M | |||
| Low | 617.4M | 695.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 32.5% | 34.3% | |||
| Avg | 26.2% | 22.0% | |||
| Low | 18.4% | 5.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.43 | 2.10 | |||
| Avg | -1.90 | 0.01 | |||
| Low | -2.76 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.